Answers are grounded in this paper and cite their sources.
The authors reviewed the clinical features and outcome of Miller Fisher syndrome (MFS) for 50 consecutive patients with MFS including 28 patients who received no immunotherapy. Besides the characteristic clinical triad (ophthalmoplegia, ataxia, and areflexia), pupillary abnormalities, blepharoptosis, and facial palsy are frequent in MFS, whereas sensory loss is unusual despite the presence of profound ataxia. Patients with MFS usually had good recovery and no residual deficits.
No takes yet. Share an insight, caveat, or question.
Mori et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: